WallStreetZenWallStreetZen

NYSE: SCL
Stepan Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SCL

Based on 1 analyst offering 12 month price targets for Stepan Co

Min Forecast
$75.00+44.04%
Avg Forecast
$75.00+44.04%
Max Forecast
$75.00+44.04%

Should I buy or sell SCL stock?

Based on 1 analyst offering ratings for Stepan Co.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SCL's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SCL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SCL stock forecasts and price targets.

SCL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-23

1 of 1

Forecast return on equity

Is SCL forecast to generate an efficient return?

Company
N/A
Industry
35.2%
Market
169.74%

Forecast return on assets

Is SCL forecast to generate an efficient return on assets?

Company
N/A
Industry
11.92%

SCL earnings per share forecast

What is SCL's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.71
Avg 2 year Forecast
$3.91

SCL revenue forecast

What is SCL's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.5B+8.26%
Avg 2 year Forecast
$2.7B+14.92%
Avg 3 year Forecast
$2.9B+24.44%
SCL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCL revenue growth forecast

How is SCL forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
7.37%
Industry
5.03%
Market
13.75%
SCL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCL vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
SCL$51.40$75.00+45.91%Buy
ODC$75.23N/AN/A
ECVT$13.33$14.25+6.90%Strong Buy
KRO$6.80$5.00-26.47%Strong Sell
KOP$39.63$55.00+38.78%Buy
View Top Specialty Chemical Stocks

Stepan Co Stock Forecast FAQ

Is Stepan Co Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: SCL) stock is to Buy SCL stock.

Out of 1 analyst, 0 (0%) are recommending SCL as a Strong Buy, 1 (100%) are recommending SCL as a Buy, 0 (0%) are recommending SCL as a Hold, 0 (0%) are recommending SCL as a Sell, and 0 (0%) are recommending SCL as a Strong Sell.

If you're new to stock investing, here's how to buy Stepan Co stock.

What is SCL's earnings growth forecast for 2026-2027?

(NYSE: SCL) Stepan Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 12.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.38%.

Stepan Co's earnings in 2026 is -$14,222,000.On average, 3 Wall Street analysts forecast SCL's earnings for 2026 to be $61,596,261, with the lowest SCL earnings forecast at $52,308,783, and the highest SCL earnings forecast at $72,023,947.

In 2027, SCL is forecast to generate $88,779,566 in earnings, with the lowest earnings forecast at $85,029,596 and the highest earnings forecast at $93,488,037.

What is SCL's revenue growth forecast for 2026-2028?

(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 7.37% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.

Stepan Co's revenue in 2026 is $2,343,368,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $57,623,700,451, with the lowest SCL revenue forecast at $55,238,801,536, and the highest SCL revenue forecast at $60,644,572,410. On average, 3 Wall Street analysts forecast SCL's revenue for 2027 to be $61,166,978,839, with the lowest SCL revenue forecast at $58,441,380,079, and the highest SCL revenue forecast at $64,573,977,289.

In 2028, SCL is forecast to generate $66,232,049,868 in revenue, with the lowest revenue forecast at $64,278,704,090 and the highest revenue forecast at $68,866,795,336.

What is SCL's forecast return on assets (ROA) for 2026-2029?

(NYSE: SCL) forecast ROA is N/A, which is lower than the forecast US Specialty Chemicals industry average of 11.92%.

What is SCL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SCL price target, the average SCL price target is $75.00, with the highest SCL stock price forecast at $75.00 and the lowest SCL stock price forecast at $75.00.

The Wall Street analyst predicted that Stepan Co's share price could reach $75.00 by Jan 23, 2027. The average Stepan Co stock price prediction forecasts a potential upside of 45.91% from the current SCL share price of $51.40.

What is SCL's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: SCL) Stepan Co's current Earnings Per Share (EPS) is -$0.62. On average, analysts forecast that SCL's EPS will be $2.71 for 2026, with the lowest EPS forecast at $2.30, and the highest EPS forecast at $3.17. In 2027, SCL's EPS is forecast to hit $3.91 (min: $3.74, max: $4.12).

What is SCL's forecast return on equity (ROE) for 2026-2029?

(NYSE: SCL) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.